STOCK TITAN

Henry Schein (HSIC) Stock News

HSIC Nasdaq

Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.

Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.

Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.

Rhea-AI Summary

Henry Schein (NASDAQ: HSIC) announces its role as a founding sponsor of Women in DSO®, supporting the inaugural event ‘Empower and Grow 2022’ from March 9-11, 2022, in Las Vegas. The company will sponsor keynote speaker Bonnie St. John, a renowned Paralympic medalist. This initiative reflects Henry Schein’s commitment to enhancing female leadership in the dental industry, providing mentorship, networking opportunities, and resources through their Women's Leadership Network.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
none
-
Rhea-AI Summary

Henry Schein, Inc. (NASDAQ: HSIC) showcased a diverse array of products and services at the 2022 Chicago Midwinter Dental Meeting, emphasizing advancements in dental practice performance. Key highlights included the launch of the Medit i700 intraoral scanner and Septodont BioRoot Flow root canal sealer. The company also introduced Jarvis for Private Practices, enhancing practice analytics. Visitors engaged with leaders from multiple renowned dental product companies while exploring solutions aimed at optimizing workflow efficiency. The meeting, held from February 24-26, 2022, provided a platform for networking and learning innovations in oral health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
none
-
Rhea-AI Summary

Henry Schein, Inc. (NASDAQ: HSIC) has launched a virtual program titled “Optimism and Opportunities in Oral Health,” coinciding with the Chicago Midwinter Dental Meeting. This on-demand program features discussions with ASDA leaders and Henry Schein executives, focusing on the dental profession's evolution. CEO Stanley Bergman emphasized the importance of sharing insights for the advancement of dentistry. This initiative reflects the company's commitment to oral health as part of overall healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
Rhea-AI Summary

Zahn Dental, the dental laboratory business of Henry Schein, has committed $150,000 to Feeding America to aid communities facing food insecurity, particularly seniors. This contribution aims to enhance access to nutrition and combat malnutrition among elderly individuals, who often suffer from chronic conditions affecting their dietary needs. Zahn's supplier partners will also support this initiative. Feeding America highlights that over 38 million people in the U.S. face food insecurity, an issue worsened by the pandemic. This partnership aligns with Zahn's mission to link oral health with overall well-being.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
none
-
Rhea-AI Summary

Henry Schein reported fourth-quarter 2021 net sales of $3.3 billion, a 5.2% increase year-over-year. GAAP diluted EPS from continuing operations rose to $1.05, up from $0.99 a year earlier. Non-GAAP diluted EPS also increased to $1.07 from $1.00.

The company projects 2022 GAAP diluted EPS between $4.75 and $4.91, reflecting 7% to 10% growth from 2021. Global dental sales reached $2.0 billion for the quarter, a 9.4% rise, while medical sales declined by 3.2%. The company continues to focus on operational improvements and technology services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.98%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
none
Rhea-AI Summary

Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, announced its participation in two virtual investor events in February 2022. The events include the Baird 2022 Sustainability Conference on February 23, 2022, at 2:20 p.m. Eastern and the Jefferies 2022 Dental Summit on February 24, 2022, at 1:00 p.m. Eastern. The Baird conference will be available for live webcast, with replays accessible on their website. Henry Schein reported $10.1 billion in sales for 2020, highlighting its significant impact in the healthcare industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.66%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
none

FAQ

What is the current stock price of Henry Schein (HSIC)?

The current stock price of Henry Schein (HSIC) is $86.43 as of July 4, 2026.

What is the market cap of Henry Schein (HSIC)?

The market cap of Henry Schein (HSIC) is approximately 9.8B.